Iagaru A - Search Results

1

Prognostic value of metabolic tumor volume and velocity in predicting head-and-neck cancer outcomes.

Chu KP, Murphy JD, La TH, Krakow TE, Iagaru A, Graves EE, Hsu A, Maxim PG, Loo B, Chang DT, Le QT. Chu KP, et al. Among authors: iagaru a. Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1521-7. doi: 10.1016/j.ijrobp.2011.10.022. Epub 2012 Jan 21. Int J Radiat Oncol Biol Phys. 2012. PMID: 22270168 Free PMC article.

2

Merkel cell carcinoma: Is there a role for 2-deoxy-2-[f-18]fluoro-D-glucose-positron emission tomography/computed tomography?

Iagaru A, Quon A, McDougall IR, Gambhir SS. Iagaru A, et al. Mol Imaging Biol. 2006 Jul-Aug;8(4):212-7. doi: 10.1007/s11307-006-0047-2. Mol Imaging Biol. 2006. PMID: 16724293

3

2-Deoxy-2-[F-18]fluoro-D-glucose positron emission tomography/computed tomography in the management of melanoma.

Iagaru A, Quon A, Johnson D, Gambhir SS, McDougall IR. Iagaru A, et al. Mol Imaging Biol. 2007 Jan-Feb;9(1):50-7. doi: 10.1007/s11307-006-0065-0. Mol Imaging Biol. 2007. PMID: 17051322

4

Follicular dendritic sarcoma within a focus of Castleman's disease. Serial FDG PET/CT in the follow up of recurrence with histopathologic confirmation.

Iagaru A, Mari C, Sam Gambhir S. Iagaru A, et al. Rev Esp Med Nucl. 2007 Jan-Feb;26(1):40-5. doi: 10.1157/13097380. Rev Esp Med Nucl. 2007. PMID: 17286947

5

Advances in metabolic imaging for surgical oncology.

Iagaru A, Quon A. Iagaru A, et al. Surg Oncol Clin N Am. 2007 Apr;16(2):273-92. doi: 10.1016/j.soc.2007.03.007. Surg Oncol Clin N Am. 2007. PMID: 17560512 Review.

6

F-18 FDG PET/CT in the management of thyroid cancer.

Iagaru A, Kalinyak JE, McDougall IR. Iagaru A, et al. Clin Nucl Med. 2007 Sep;32(9):690-5. doi: 10.1097/RLU.0b013e318125037a. Clin Nucl Med. 2007. PMID: 17710020

7

18F-FDG PET/CT evaluation of patients with ovarian carcinoma.

Iagaru AH, Mittra ES, McDougall IR, Quon A, Gambhir SS. Iagaru AH, et al. Nucl Med Commun. 2008 Dec;29(12):1046-51. doi: 10.1097/MNM.0b013e32831089cb. Nucl Med Commun. 2008. PMID: 18987524 Free PMC article.

8

(18)F-FDG-PET/CT evaluation of response to treatment in lymphoma: when is the optimal time for the first re-evaluation scan?

Iagaru A, Wang Y, Mari C, Quon A, Goris ML, Horning S, Gambhir SS. Iagaru A, et al. Hell J Nucl Med. 2008 Sep-Dec;11(3):153-6. Hell J Nucl Med. 2008. PMID: 19081857

9

Evaluation by 18F-FDG-PET of patients with anal squamous cell carcinoma.

Iagaru A, Kundu R, Jadvar H, Nagle D. Iagaru A, et al. Hell J Nucl Med. 2009 Jan-Apr;12(1):26-9. Hell J Nucl Med. 2009. PMID: 19330178

10

Efficacy of 18F-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma.

Mittra E, El-Maghraby T, Rodriguez CA, Quon A, McDougall IR, Gambhir SS, Iagaru A. Mittra E, et al. Among authors: iagaru a. Eur J Nucl Med Mol Imaging. 2009 Dec;36(12):1952-9. doi: 10.1007/s00259-009-1206-x. Eur J Nucl Med Mol Imaging. 2009. PMID: 19585114 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

237 results

Search Page

Filters